TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3.Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2.Breakdown of Primary Respondents
3.5. Forecasting Modality
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL VETERINARY BIOMARKERS MARKET, BY ANIMAL TYPE
6.1. Overview
6.2. Companion Animals
6.3. Production Animals
7. GLOBAL VETERINARY BIOMARKERS MARKET, BY PRODUCT TYPE
7.1. Overview
7.2. Biomarkers, Kits & Reagents
7.3. Biomarker Readers
8. GLOBAL VETERINARY BIOMARKERS MARKET, BY APPLICATION
8.1. Overview
8.2. Disease Diagnostics
8.3. Preclinical Research
8.4. Others
9. GLOBAL VETERINARY BIOMARKERS MARKET, BY DISEASE TYPE
9.1. Overview
9.2. Inflammatory & Infectious Diseases
9.3. Cardiovascular Diseases
9.4. Skeletal Muscle Diseases
9.5. Tumor
9.6. Others
10. GLOBAL VETERINARY BIOMARKERS MARKET, BY REGION
10.1. Overview
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.3. Europe
10.3.1. Germany
10.3.2. France
10.3.3. U.K
10.3.4. Italy
10.3.5. Spain
10.3.6. Rest of Europe
10.4. Asia-Pacific
10.4.1. China
10.4.2. India
10.4.3. Japan
10.4.4. South Korea
10.4.5. Australia
10.4.6. Rest of Asia-Pacific
10.5. Rest of the World
10.5.1. Middle East
10.5.2. Africa
10.5.3. Latin America
11. COMPETITIVE LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market Share Analysis
11.4. Major Growth Strategy in the Global Veterinary biomarkers Market,
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Global Veterinary biomarkers Market,
11.7. Key developments and Growth Strategies
11.7.1. New Animal Type Launch/Product Type Application
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales & Operating Income, 2022
11.8.2. Major Players R&D Expenditure. 2022
12. COMPANY PROFILES
12.1. ZOETIS
12.1.1. Company Overview
12.1.2. Financial Overview
12.1.3. Animal Types Offered
12.1.4. Key Developments
12.1.5. SWOT Analysis
12.1.6. Key Strategies
12.2. Virbac
12.2.1. Company Overview
12.2.2. Financial Overview
12.2.3. Animal Types Offered
12.2.4. Key Developments
12.2.5. SWOT Analysis
12.2.6. Key Strategies
12.3. LIFE DIAGNOSTICS.
12.3.1. Company Overview
12.3.2. Financial Overview
12.3.3. Animal Types Offered
12.3.4. Key Developments
12.3.5. SWOT Analysis
12.3.6. Key Strategies
12.4. ACUVET BIOTECH
12.4.1. Company Overview
12.4.2. Financial Overview
12.4.3. Animal Types Offered
12.4.4. Key Developments
12.4.5. SWOT Analysis
12.4.6. Key Strategies
12.5. Merck & Co., Inc.
12.5.1. Company Overview
12.5.2. Financial Overview
12.5.3. Animal Types Offered
12.5.4. Key Developments
12.5.5. SWOT Analysis
12.5.6. Key Strategies
12.6. IDEXX LABORATORIES, INC.
12.6.1. Company Overview
12.6.2. Financial Overview
12.6.3. Animal Types Offered
12.6.4. Key Developments
12.6.5. SWOT Analysis
12.6.6. Key Strategies
12.7. MI:RNA Diagnostics Ltd
12.7.1. Company Overview
12.7.2. Financial Overview
12.7.3. Animal Types Offered
12.7.4. Key Developments
12.7.5. SWOT Analysis
12.7.6. Key Strategies
12.8. Mercodia AB.
12.8.1. Company Overview
12.8.2. Financial Overview
12.8.3. Animal Types Offered
12.8.4. Key Developments
12.8.5. SWOT Analysis
12.8.6. Key Strategies
12.9. Antech Diagnostics, Inc.
12.9.1. Company Overview
12.9.2. Financial Overview
12.9.3. Animal Types Offered
12.9.4. Key Developments
12.9.5. SWOT Analysis
12.9.6. Key Strategies
12.10. Avacta Animal Health Limited
12.10.1. Company Overview
12.10.2. Financial Overview
12.10.3. Animal Types Offered
12.10.4. Key Developments
12.10.5. SWOT Analysis
12.10.6. Key Strategies
13. APPENDIX
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL VETERINARY BIOMARKERS MARKET, SYNOPSIS, 2018-2032
TABLE 2 GLOBAL VETERINARY BIOMARKERS MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)
TABLE 3 GLOBAL VETERINARY BIOMARKERS MARKET, BY ANIMAL TYPE, 2018-2032 (USD BILLION)
TABLE 4 GLOBAL VETERINARY BIOMARKERS MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 5 GLOBAL VETERINARY BIOMARKERS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 6 GLOBAL VETERINARY BIOMARKERS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 7 NORTH AMERICA VETERINARY BIOMARKERS MARKET, BY ANIMAL TYPE, 2018-2032 (USD BILLION)
TABLE 8 NORTH AMERICA VETERINARY BIOMARKERS MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 9 NORTH AMERICA VETERINARY BIOMARKERS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 10 NORTH AMERICA VETERINARY BIOMARKERS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 11 NORTH AMERICA VETERINARY BIOMARKERS MARKET, BY COUNTRY, 2018-2032 (USD BILLION)
TABLE 12 U.S. VETERINARY BIOMARKERS MARKET, BY ANIMAL TYPE, 2018-2032 (USD BILLION)
TABLE 13 U.S. VETERINARY BIOMARKERS MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 14 U.S. VETERINARY BIOMARKERS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 15 U.S. VETERINARY BIOMARKERS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 16 CANADA VETERINARY BIOMARKERS MARKET, BY ANIMAL TYPE, 2018-2032 (USD BILLION)
TABLE 17 CANADA VETERINARY BIOMARKERS MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 18 CANADA VETERINARY BIOMARKERS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 19 CANADA VETERINARY BIOMARKERS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 20 EUROPE VETERINARY BIOMARKERS MARKET, BY ANIMAL TYPE, 2018-2032 (USD BILLION)
TABLE 21 EUROPE VETERINARY BIOMARKERS MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 22 EUROPE VETERINARY BIOMARKERS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 23 EUROPE VETERINARY BIOMARKERS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 24 EUROPE VETERINARY BIOMARKERS MARKET, BY COUNTRY, 2018-2032 (USD BILLION)
TABLE 25 GERMANY VETERINARY BIOMARKERS MARKET, BY ANIMAL TYPE, 2018-2032 (USD BILLION)
TABLE 26 GERMANY VETERINARY BIOMARKERS MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 27 GERMANY VETERINARY BIOMARKERS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 28 GERMANY VETERINARY BIOMARKERS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 29 FRANCE VETERINARY BIOMARKERS MARKET, BY ANIMAL TYPE, 2018-2032 (USD BILLION)
TABLE 30 FRANCE VETERINARY BIOMARKERS MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 31 FRANCE VETERINARY BIOMARKERS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 32 FRANCE VETERINARY BIOMARKERS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 33 ITALY VETERINARY BIOMARKERS MARKET, BY ANIMAL TYPE, 2018-2032 (USD BILLION)
TABLE 34 ITALY VETERINARY BIOMARKERS MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 35 ITALY VETERINARY BIOMARKERS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 36 ITALY VETERINARY BIOMARKERS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 37 SPAIN VETERINARY BIOMARKERS MARKET, BY ANIMAL TYPE, 2018-2032 (USD BILLION)
TABLE 38 SPAIN VETERINARY BIOMARKERS MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 39 SPAIN VETERINARY BIOMARKERS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 40 SPAIN VETERINARY BIOMARKERS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 41 U.K VETERINARY BIOMARKERS MARKET, BY ANIMAL TYPE, 2018-2032 (USD BILLION)
TABLE 42 U.K VETERINARY BIOMARKERS MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 43 U.K VETERINARY BIOMARKERS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 44 U.K VETERINARY BIOMARKERS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 45 REST OF EUROPE VETERINARY BIOMARKERS MARKET, BY ANIMAL TYPE, 2018-2032 (USD BILLION)
TABLE 46 REST OF EUROPE VETERINARY BIOMARKERS MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 47 REST OF EUROPE VETERINARY BIOMARKERS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 48 REST OF EUROPE VETERINARY BIOMARKERS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 49 ASIA PACIFIC VETERINARY BIOMARKERS MARKET, BY ANIMAL TYPE, 2018-2032 (USD BILLION)
TABLE 50 ASIA PACIFIC VETERINARY BIOMARKERS MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 51 ASIA PACIFIC VETERINARY BIOMARKERS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 52 ASIA PACIFIC VETERINARY BIOMARKERS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 53 ASIA PACIFIC VETERINARY BIOMARKERS MARKET, BY COUNTRY, 2018-2032 (USD BILLION)
TABLE 54 JAPAN VETERINARY BIOMARKERS MARKET, BY ANIMAL TYPE, 2018-2032 (USD BILLION)
TABLE 55 JAPAN VETERINARY BIOMARKERS MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 56 JAPAN VETERINARY BIOMARKERS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 57 JAPAN VETERINARY BIOMARKERS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 58 CHINA VETERINARY BIOMARKERS MARKET, BY ANIMAL TYPE, 2018-2032 (USD BILLION)
TABLE 59 CHINA VETERINARY BIOMARKERS MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 60 CHINA VETERINARY BIOMARKERS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 61 CHINA VETERINARY BIOMARKERS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 62 INDIA VETERINARY BIOMARKERS MARKET, BY ANIMAL TYPE, 2018-2032 (USD BILLION)
TABLE 63 INDIA VETERINARY BIOMARKERS MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 64 INDIA VETERINARY BIOMARKERS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 65 INDIA VETERINARY BIOMARKERS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 66 AUSTRALIA VETERINARY BIOMARKERS MARKET, BY ANIMAL TYPE, 2018-2032 (USD BILLION)
TABLE 67 AUSTRALIA VETERINARY BIOMARKERS MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 68 AUSTRALIA VETERINARY BIOMARKERS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 69 AUSTRALIA VETERINARY BIOMARKERS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 70 SOUTH KOREA VETERINARY BIOMARKERS MARKET, BY ANIMAL TYPE, 2018-2032 (USD BILLION)
TABLE 71 SOUTH KOREA VETERINARY BIOMARKERS MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 72 SOUTH KOREA VETERINARY BIOMARKERS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 73 SOUTH KOREA VETERINARY BIOMARKERS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 74 REST OF ASIA-PACIFIC VETERINARY BIOMARKERS MARKET, BY ANIMAL TYPE, 2018-2032 (USD BILLION)
TABLE 75 REST OF ASIA-PACIFIC VETERINARY BIOMARKERS MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 76 REST OF ASIA-PACIFIC VETERINARY BIOMARKERS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 77 REST OF ASIA-PACIFIC VETERINARY BIOMARKERS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 78 REST OF WORLD VETERINARY BIOMARKERS MARKET, BY ANIMAL TYPE, 2018-2032 (USD BILLION)
TABLE 79 REST OF WORLD VETERINARY BIOMARKERS MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 80 REST OF WORLD VETERINARY BIOMARKERS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 81 REST OF WORLD VETERINARY BIOMARKERS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 82 REST OF WORLD VETERINARY BIOMARKERS MARKET, BY COUNTRY, 2018-2032 (USD BILLION)
TABLE 83 MIDDLE EAST VETERINARY BIOMARKERS MARKET, BY ANIMAL TYPE, 2018-2032 (USD BILLION)
TABLE 84 MIDDLE EAST VETERINARY BIOMARKERS MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 85 MIDDLE EAST VETERINARY BIOMARKERS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 86 MIDDLE EAST VETERINARY BIOMARKERS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 87 AFRICA VETERINARY BIOMARKERS MARKET, BY ANIMAL TYPE, 2018-2032 (USD BILLION)
TABLE 88 AFRICA VETERINARY BIOMARKERS MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 89 AFRICA VETERINARY BIOMARKERS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 90 AFRICA VETERINARY BIOMARKERS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
TABLE 91 LATIN AMERICA VETERINARY BIOMARKERS MARKET, BY ANIMAL TYPE, 2018-2032 (USD BILLION)
TABLE 92 LATIN AMERICA VETERINARY BIOMARKERS MARKET, BY PRODUCT TYPE, 2018-2032 (USD BILLION)
TABLE 93 LATIN AMERICA VETERINARY BIOMARKERS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 94 LATIN AMERICA VETERINARY BIOMARKERS MARKET, BY DISEASE TYPE, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL VETERINARY BIOMARKERS MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL VETERINARY BIOMARKERS MARKET
FIGURE 4 GLOBAL VETERINARY BIOMARKERS MARKET, SHARE (%), BY ANIMAL TYPE, 2022
FIGURE 5 GLOBAL VETERINARY BIOMARKERS MARKET, SHARE (%), BY PRODUCT TYPE, 2022
FIGURE 6 GLOBAL VETERINARY BIOMARKERS MARKET, SHARE (%), BY APPLICATION, 2022
FIGURE 7 GLOBAL VETERINARY BIOMARKERS MARKET, SHARE (%), BY DISEASE TYPE, 2022
FIGURE 8 GLOBAL VETERINARY BIOMARKERS MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 NORTH AMERICA: VETERINARY BIOMARKERS MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 EUROPE: VETERINARY BIOMARKERS MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 ASIA-PACIFIC: VETERINARY BIOMARKERS MARKET, SHARE (%), BY REGION, 2022
FIGURE 12 REST OF THE WORLD: VETERINARY BIOMARKERS MARKET, SHARE (%), BY REGION, 2022
FIGURE 13 GLOBAL VETERINARY BIOMARKERS MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
FIGURE 14 ZOETIS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 ZOETIS: SWOT ANALYSIS
FIGURE 16 VIRBAC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 VIRBAC: SWOT ANALYSIS
FIGURE 18 LIFE DIAGNOSTICS.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 LIFE DIAGNOSTICS.: SWOT ANALYSIS
FIGURE 20 ACUVET BIOTECH: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 ACUVET BIOTECH: SWOT ANALYSIS
FIGURE 22 MERCK & CO., INC..: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 MERCK & CO., INC..: SWOT ANALYSIS
FIGURE 24 IDEXX LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 IDEXX LABORATORIES, INC.: SWOT ANALYSIS
FIGURE 26 MI:RNA DIAGNOSTICS LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 MI:RNA DIAGNOSTICS LTD: SWOT ANALYSIS
FIGURE 28 MERCODIA AB.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 MERCODIA AB.: SWOT ANALYSIS
FIGURE 30 ANTECH DIAGNOSTICS, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 ANTECH DIAGNOSTICS, INC.: SWOT ANALYSIS
FIGURE 32 AVACTA ANIMAL HEALTH LIMITED.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 AVACTA ANIMAL HEALTH LIMITED.: SWOT ANALYSIS
